{"id":"NCT02443805","sponsor":"Stallergenes Greer","briefTitle":"Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-29","primaryCompletion":"2018-06-25","completion":"2018-06-25","firstPosted":"2015-05-14","resultsPosted":"2019-09-25","lastUpdate":"2019-10-14"},"enrollment":1607,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rhinitis, Allergic, Perennial","House Dust Mite Allergy"],"interventions":[{"type":"BIOLOGICAL","name":"300 IR","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"300 IR","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study was to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.","primaryOutcome":{"measure":"Total Combined Score","timeFrame":"12 months","effectByArm":[{"arm":"300 IR","deltaMin":3.62,"sd":null},{"arm":"Placebo","deltaMin":4.35,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":2,"countries":["United States","France"]},"refs":{"pmids":["39035788","38225952"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":800},"commonTop":["Nasopharyngitis","Oral pruritus","Throat irritation","Ear pruritus","Headache"]}}